TIL Earnings — Instil Bio, Inc. Common Stock Post-ER Performance | BigEarnings
TIL — Instil Bio, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$8.07
Market Cap$54.7M
P/E—
52W Range$5.67 – $42.79
Next Earnings2026-08-12
About Instil Bio, Inc. Common Stock
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
